VLST Corporation was founded on the belief that the challenge in developing new therapeutics for the treatment of inflammatory diseases is not a lack of suitable targets but the identification of targets that have true therapeutic potential.

VLST has developed a streamlined and efficient proprietary platform that rapidly yields novel biological therapeutic compositions of matter with a far greater likelihood of success in clinical trials, particularly in autoimmune and inflammatory disorders.